18-Dec-2025
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
Business Wire (Fri, 5-Dec 8:00 AM ET)
CONMED Corporation Announces Third Quarter 2025 Financial Results
Business Wire (Wed, 5-Nov 4:05 PM ET)
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
Business Wire (Thu, 2-Oct 4:05 PM ET)
CONMED Corporation Sees Premarket Decline Following Financial Results
Market Chameleon (Thu, 6-Feb 3:34 AM ET)
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Conmed trades on the NYSE stock market under the symbol CNMD.
As of December 18, 2025, CNMD stock price climbed to $40.39 with 498,229 million shares trading.
CNMD has a beta of 0.64, meaning it tends to be less sensitive to market movements. CNMD has a correlation of 0.09 to the broad based SPY ETF.
CNMD has a market cap of $1.25 billion. This is considered a Small Cap stock.
Last quarter Conmed reported $338 million in Revenue and $1.08 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.03.
In the last 3 years, CNMD traded as high as $138.47 and as low as $38.32.
The top ETF exchange traded funds that CNMD belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
CNMD has underperformed the market in the last year with a price return of -40.6% while the SPY ETF gained +16.6%. CNMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.5% and -8.7%, respectively, while the SPY returned +2.7% and -1.2%, respectively.
CNMD support price is $38.69 and resistance is $40.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNMD shares will trade within this expected range on the day.